複数治療歴のある胃がんに対するトリフルリジン・チピラシル塩酸塩(TAS-102):ESMO World GI Congress 2018【ESMO】

TAGS試験でOS中央値を2カ月改善

ESMO World GI Congress 2018: Trifluridine/Tipiracil Effective in Patients with Heavily Pretreated Metastatic Gastric Cancer
TAGS study shows two-month improvement in median overall survival

 

 

 

コメント

Leave a comment

Your email address will not be published.


*